USH2014 Presentations - Dr. José M. Millán, Functional Genetics
Delivered by Dr. José M. Millán at the International Symposium on Usher Syndrome.
Download the presentation slides here.
Unidad de Genética, Hospital Universitario La Fe, Fundación para la Investigación del Hospital La Fe, Valencia, Spain
The first purpose of this study was to determine the pathologic nature of eighteen USH1 putative splicing variants found in our series and their effect in the splicing process by minigene assays. These variants were selected according to bioinformatic analysis.
The second aim was to analyze the USH1 transcripts, obtained from nasal epithelial cells samples of our patients, in order to corroborate the observed effect of mutations by minigenes in patient’s tissues.
The last objective was to evaluate the nasal ciliary beat frequency in patients with USH1 and compare it with control subjects.
In silico analysis were performed using four bioinformatic programs: NNSplice, Human Splicing Finder, NetGene2 and Spliceview. Afterward, minigenes based on the pSPL3 vector were used to investigate the implication of selected changes in the mRNA processing. To observe the effect of mutations in the patient’s tissues, RNA was extracted from nasal epithelial cells and RT-PCR analyses were performed.
Four MYO7A (c.470G.A, c.1342_1343delAG, c.5856G.A and c.3652G.A), three CDH23 (c.2289+1G.A, c.6049G.A and c.8722+1delG) and one PCDH15 (c.3717+2dupTT) variants were observed to affect the splicing process by minigene assays and/or transcripts analysis obtained from nasal cells. Based on our results, minigenes are a good approach to determine the implication of identified variants in the mRNA processing, and the analysis of RNA obtained from nasal epithelial cells is an alternative method to discriminate neutral Usher variants from those with a pathogenic effect on the splicing process. In addition, we could observe that the nasal ciliated epithelium of USH1 patients shows a lower ciliary beat frequency than control subjects.